Tapewire

Nasdaq · USD

LFVN

Lifevantage Corp

Export transactions ↓
Tapewire entity
6941
SEC CIK
0000849146
Parsed reports
418

Last 12 months

Inside the activity.

8 purchase rows · 6 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 202510
Jan 202600
Feb 202630
Mar 202620
Apr 202600
May 202600
Jun 202611
Jul 202600
Aug 202600
Sep 202612
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 13, 2017 Filed Feb 14, 2017 22:48 UTC
Rose JustinChief Sales Officer
PurchaseCommon Stock 1,500 $6.75 $10,125.00
Disclosure

SEC source: 0000849146-17-000024 · wf-form4_148711250212433.xml · nonDerivative · entry 1

Rose Justin · CIK 0001649432 · Chief Sales Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,794

Read SEC document
February 13, 2017 Filed Feb 14, 2017 21:17 UTC
Jensen Darren JayDirector · Chief Executive Officer
PurchaseCommon Stock 1,500 $6.75 $10,125.00
Disclosure

SEC source: 0000849146-17-000017 · wf-form4_148710691839530.xml · nonDerivative · entry 1

Jensen Darren Jay · CIK 0001642848 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 144,958

Read SEC document
January 11, 2017 Filed Jan 13, 2017 20:53 UTC GrantCommon Stock 14,662 $0.00 $0.00
Disclosure

SEC source: 0000849146-17-000004 · wf-form4_148434077134601.xml · nonDerivative · entry 1

TOOLE DAVID J · CIK 0000939496 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,662

F1 · shares: These shares were granted to the reporting person pursuant to a restricted stock award effective January 11, 2017. The award, which was made pursuant to the issuer's outside director compensation program, compensates the reporting person for his initial one year of service on the Board of Directors, which commenced in January 2016, and as such was fully vested at grant.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.